# Definitions of Done

**Version:** 1.0.0
**Created:** December 29, 2025
**Status:** Planning Phase

---

## Overview

This document defines specific, measurable completion criteria for each of the 100 features. A feature is "Done" only when ALL criteria are met.

---

## Universal Definition of Done

Every feature must satisfy these base criteria before feature-specific criteria:

### Code Quality
- [ ] All new code follows project style guide (black, isort, flake8)
- [ ] Type hints on all public functions
- [ ] No increase in cyclomatic complexity (radon grade B or better)
- [ ] No new security vulnerabilities (bandit clean)

### Testing
- [ ] Unit test coverage ≥90% for new code
- [ ] All existing tests still pass
- [ ] Integration tests added where applicable
- [ ] Edge cases explicitly tested

### Documentation
- [ ] Public API documented with docstrings
- [ ] Usage examples in docstring or README
- [ ] Architecture decisions documented (if significant)
- [ ] CHANGELOG updated

### Review
- [ ] Code review completed by at least one other developer
- [ ] No unresolved review comments
- [ ] CI pipeline passes

---

## Category 1: Disease Analyzers (Features 1-15)

### Universal DoD for Disease Analyzers
- [ ] Spearman correlation ≥0.75 on validation set
- [ ] Handles all known resistance mutations for target drugs
- [ ] Uncertainty quantification integrated
- [ ] Can process 1000 sequences in <10 seconds
- [ ] Comprehensive test suite with known mutation test cases

### Feature 1: Dengue Virus Analyzer
- [ ] Supports all 4 serotypes (DENV-1 through DENV-4)
- [ ] NS3 protease and NS5 polymerase resistance predictions
- [ ] Validated against published antiviral resistance data
- [ ] Cross-serotype analysis capability
- [ ] Test coverage includes serotype-specific mutations

### Feature 2: Zika Virus Analyzer
- [ ] NS2B-NS3 protease resistance predictions
- [ ] NS5 RdRp resistance predictions
- [ ] Validated against published resistance data
- [ ] Cross-reactivity with Dengue noted in output
- [ ] Congenital Zika syndrome marker annotations

### Feature 3: Norovirus Analyzer
- [ ] Covers GI and GII genogroups
- [ ] RdRp resistance mutations for ribavirin, CMX521
- [ ] Capsid neutralization escape predictions
- [ ] Validated against outbreak surveillance data
- [ ] Seasonal variant tracking capability

### Feature 4: Enterovirus Analyzer
- [ ] EV-A71, EV-D68 primary focus
- [ ] 3C protease inhibitor resistance
- [ ] Capsid-binding inhibitor resistance (pleconaril)
- [ ] Validated against clinical resistance data
- [ ] Serotype classification included

### Feature 5: West Nile Virus Analyzer
- [ ] NS3 helicase and NS5 RdRp targets
- [ ] Validated against available resistance data
- [ ] Geographic lineage classification
- [ ] Neuroinvasive phenotype markers
- [ ] Cross-validated with JEV serocomplex

### Feature 6: Chikungunya Analyzer
- [ ] nsP2 protease and nsP4 RdRp targets
- [ ] Validated against experimental resistance data
- [ ] E2 glycoprotein escape mutations
- [ ] Chronic arthritis marker annotations
- [ ] Lineage classification (ECSA, Asian, IOL)

### Feature 7: HPV Analyzer
- [ ] E6/E7 oncogene variant analysis
- [ ] High-risk vs low-risk classification
- [ ] Vaccine escape variant detection
- [ ] Integration site predictions
- [ ] Validated against IARC reference sequences

### Feature 8: EBV Analyzer
- [ ] Ganciclovir resistance (UL97 kinase)
- [ ] Acyclovir resistance (TK, DNA pol)
- [ ] Latency type classification
- [ ] Oncogenic variant markers
- [ ] Validated against transplant resistance data

### Feature 9: CMV Analyzer
- [ ] Ganciclovir resistance (UL97, UL54)
- [ ] Foscarnet resistance (UL54)
- [ ] Letermovir resistance (UL56)
- [ ] Validated against transplant cohort data
- [ ] Congenital CMV markers

### Feature 10: Adenovirus Analyzer
- [ ] Cidofovir resistance (DNA polymerase)
- [ ] Species A-G classification
- [ ] Immunocompromised patient risk markers
- [ ] Validated against transplant data
- [ ] Respiratory vs enteric pathotype prediction

### Feature 11: C. difficile Analyzer
- [ ] Vancomycin and metronidazole resistance
- [ ] Fidaxomicin resistance markers
- [ ] Toxin gene variant analysis (tcdA, tcdB)
- [ ] Hypervirulent ribotype detection (027, 078)
- [ ] Validated against clinical isolate data

### Feature 12: E. coli Analyzer
- [ ] ESBL and carbapenemase detection
- [ ] Fluoroquinolone resistance (gyrA, parC)
- [ ] Aminoglycoside resistance genes
- [ ] Pathotype classification (UPEC, EHEC, etc.)
- [ ] Validated against AMR surveillance data

### Feature 13: Klebsiella Analyzer
- [ ] KPC, NDM, OXA-48 carbapenemase detection
- [ ] Colistin resistance (mcr genes, PmrAB)
- [ ] Hypervirulent strain markers
- [ ] Validated against hospital surveillance data
- [ ] Multi-drug resistance phenotype prediction

### Feature 14: Acinetobacter Analyzer
- [ ] OXA carbapenemase detection
- [ ] Colistin resistance mechanisms
- [ ] Tigecycline resistance
- [ ] Validated against ICU surveillance data
- [ ] Biofilm formation markers

### Feature 15: Pseudomonas Analyzer
- [ ] MexAB-OprM efflux pump analysis
- [ ] OprD porin loss detection
- [ ] Metallo-beta-lactamase detection
- [ ] Validated against CF patient data
- [ ] Biofilm and persistence markers

---

## Category 2: Encoding Methods (Features 16-25)

### Universal DoD for Encoding Methods
- [ ] Encoder class implements standard interface
- [ ] Benchmark shows ≥2% improvement or justified trade-off
- [ ] Memory efficient (≤2x baseline memory)
- [ ] Integrates with existing VAE architectures
- [ ] Mathematical derivation documented

### Feature 16: 5-adic Amino Acid Encoder
- [ ] Maps 20 amino acids to 5-adic representation
- [ ] Physicochemical properties preserved in metric
- [ ] Validated: similar AAs have similar representations
- [ ] Benchmark on protein-level tasks shows improvement
- [ ] Documentation includes mathematical basis

### Feature 17: 7-adic Secondary Structure Encoder
- [ ] Encodes 7 DSSP states (H, B, E, G, I, T, S)
- [ ] Integrates with structure prediction (PSIPRED or ESMFold)
- [ ] Validated: improves structure-dependent resistance
- [ ] Works with predicted and experimental structures
- [ ] Handles missing structure gracefully

### Feature 18: Multi-Prime Fusion Encoder
- [ ] Combines 2, 3, 5, 7-adic encodings
- [ ] Learnable fusion weights
- [ ] Ablation study shows complementarity
- [ ] Memory overhead <1.5x single encoding
- [ ] Fusion strategy documented

### Feature 19: Adaptive Prime Selection
- [ ] Learns optimal prime per position/gene
- [ ] Gumbel-softmax for differentiable selection
- [ ] Validates that selection is meaningful
- [ ] Interpretability: can explain prime choices
- [ ] Benchmark shows improvement over fixed primes

### Feature 20: P-adic Wavelet Encoding
- [ ] Implements p-adic Haar wavelets
- [ ] Multi-scale representation of sequences
- [ ] Efficient implementation (O(n log n))
- [ ] Validated on position-dependent resistance
- [ ] Mathematical derivation documented

### Feature 21: Codon Context Window
- [ ] ±k codon context (configurable k)
- [ ] Attention-weighted context aggregation
- [ ] Shows improvement on context-dependent mutations
- [ ] Memory efficient for long sequences
- [ ] Handles sequence boundaries gracefully

### Feature 22: Position-Aware P-adic
- [ ] Positional encoding combined with p-adic
- [ ] Learnable position embeddings
- [ ] Validated: position-sensitive resistance improved
- [ ] Works with variable-length sequences
- [ ] Position normalization for alignment

### Feature 23: Mutation-Type Embedding
- [ ] Encodes transition vs transversion
- [ ] Synonymous vs non-synonymous distinction
- [ ] Conservative vs radical amino acid change
- [ ] Improves mutation impact prediction
- [ ] Compatible with other encodings

### Feature 24: Reading Frame Encoding
- [ ] Captures frame-shift sensitivity
- [ ] Works with +1, +2, +3 frames
- [ ] Validated on frameshift-sensitive genes
- [ ] Handles programmed frameshifts
- [ ] Integration with codon encoding

### Feature 25: Synonymous Codon Encoding
- [ ] Preserves codon usage bias information
- [ ] Validated on codon-optimization tasks
- [ ] Shows species-specific patterns
- [ ] Integration with tRNA availability data
- [ ] Benchmark on expression prediction

---

## Category 3: Hyperbolic Geometry (Features 26-35)

### Universal DoD for Hyperbolic Features
- [ ] Numerically stable (no NaN/Inf in training)
- [ ] Gradient flow verified through component
- [ ] Visualization tools included
- [ ] Benchmark shows improvement on hierarchical data
- [ ] Fallback to Euclidean if instability detected

### Feature 26: Multi-Sheet Hyperbolic
- [ ] Supports multiple hyperbolic sheets
- [ ] Sheet assignment learned or specified
- [ ] Inter-sheet geodesics defined
- [ ] Validated on multi-level hierarchies (taxonomy)
- [ ] Visualization of sheet structure

### Feature 27: Hyperbolic Normalizing Flows
- [ ] Implements tangent flow on Poincare ball
- [ ] Invertible transformations
- [ ] Exact log-determinant computation
- [ ] Validated: better density estimation
- [ ] Training stable for 1000+ epochs

### Feature 28: Product Manifold Spaces
- [ ] H^n x E^m mixed spaces
- [ ] S^n x H^m for mixed curvature
- [ ] Learnable space allocation
- [ ] Validated on mixed-structure data
- [ ] Efficient distance computation

### Feature 29: Adaptive Curvature Learning
- [ ] Per-layer or per-dimension curvature
- [ ] Stable curvature gradient estimation
- [ ] Curvature interpretability analysis
- [ ] Benchmark shows task-specific adaptation
- [ ] Bounds on learned curvature

### Feature 30: Hyperbolic Attention
- [ ] Attention in Poincare ball
- [ ] Numerically stable softmax
- [ ] Multi-head hyperbolic attention
- [ ] Validated: improves hierarchical attention
- [ ] Interpretable attention patterns

### Feature 31: Geodesic Interpolation
- [ ] Smooth geodesic paths in latent space
- [ ] Interpolation preserves semantics
- [ ] Validated: drug resistance gradients
- [ ] Visualization of interpolation paths
- [ ] Handles antipodal points gracefully

### Feature 32: Hyperbolic Clustering
- [ ] K-means in hyperbolic space
- [ ] Hierarchical clustering with dendrograms
- [ ] Validated: matches known taxonomies
- [ ] Scalable to 100k+ points
- [ ] Cluster quality metrics defined

### Feature 33: Busemann Functions
- [ ] Implements Busemann coordinates
- [ ] Asymptotic direction encoding
- [ ] Validated on phylogenetic data
- [ ] Efficient computation
- [ ] Mathematical derivation documented

### Feature 34: Hyperbolic Diffusion
- [ ] Diffusion process on hyperbolic manifold
- [ ] Score-based generative model
- [ ] Validated: generates realistic sequences
- [ ] Training stability verified
- [ ] Sampling efficiency acceptable

### Feature 35: Multi-Scale Hyperbolic
- [ ] Hierarchical scales in single space
- [ ] Coarse-to-fine representations
- [ ] Validated on multi-resolution tasks
- [ ] Efficient multi-scale queries
- [ ] Scale-specific visualizations

---

## Category 4: Uncertainty & Calibration (Features 36-45)

### Universal DoD for Uncertainty Features
- [ ] Calibration error (ECE) <0.05
- [ ] Reliable confidence intervals (90% coverage)
- [ ] Computational overhead <2x baseline
- [ ] Works with all disease analyzers
- [ ] Uncertainty visualization tools

### Feature 36: Conformal Prediction
- [ ] Implements split conformal prediction
- [ ] Coverage guarantee validated empirically
- [ ] Adaptive conformal for heteroscedastic data
- [ ] Integration with clinical API
- [ ] User-specified confidence levels

### Feature 37: Temperature Scaling
- [ ] Post-hoc calibration method
- [ ] Optimal temperature search
- [ ] Validated: reduces ECE significantly
- [ ] Works with all model outputs
- [ ] Automatic temperature selection

### Feature 38: Bayesian Neural Networks
- [ ] Variational inference implementation
- [ ] Efficient posterior sampling
- [ ] Validated: epistemic uncertainty meaningful
- [ ] Memory overhead <1.5x
- [ ] Comparison with MC Dropout

### Feature 39: Ensemble Uncertainty
- [ ] Deep ensemble with N models
- [ ] Diversity regularization
- [ ] Uncertainty decomposition (epistemic/aleatoric)
- [ ] Efficient ensemble inference
- [ ] Ensemble disagreement interpretable

### Feature 40: Epistemic vs Aleatoric
- [ ] Clear separation of uncertainty types
- [ ] Visualization of both types
- [ ] Validated: epistemic high on OOD data
- [ ] Aleatoric captures inherent noise
- [ ] Clinical interpretation guidelines

### Feature 41: Out-of-Distribution Detection
- [ ] Energy-based OOD detection
- [ ] Mahalanobis distance method
- [ ] AUROC ≥0.9 on OOD benchmarks
- [ ] Integrates with clinical warnings
- [ ] Low false positive rate on ID data

### Feature 42: Selective Prediction
- [ ] Confidence-based rejection
- [ ] Risk-coverage trade-off analysis
- [ ] Validated: rejected samples have higher error
- [ ] Configurable rejection threshold
- [ ] Clinical workflow integration

### Feature 43: Uncertainty Propagation
- [ ] First-order Taylor propagation
- [ ] Monte Carlo propagation option
- [ ] Validated: propagated uncertainty accurate
- [ ] Works through full pipeline
- [ ] Efficient batch computation

### Feature 44: Calibration Under Shift
- [ ] Detects distribution shift
- [ ] Recalibration trigger mechanism
- [ ] Validated: maintains calibration under shift
- [ ] Shift magnitude estimation
- [ ] Automatic recalibration pipeline

### Feature 45: Human-in-the-Loop Uncertainty
- [ ] Active learning query strategy
- [ ] Uncertainty-based sample selection
- [ ] Expert feedback integration
- [ ] Validated: reduces labeling effort
- [ ] Feedback loop implementation

---

## Category 5: Transfer Learning (Features 46-55)

### Universal DoD for Transfer Features
- [ ] Positive transfer demonstrated (≥5% improvement)
- [ ] No catastrophic forgetting
- [ ] Few-shot performance measured
- [ ] Works across disease categories
- [ ] Transfer analysis documented

### Feature 46: Domain Adversarial Transfer
- [ ] Gradient reversal layer implemented
- [ ] Domain confusion loss
- [ ] Validated: reduces domain gap
- [ ] Hyperparameter sensitivity analysis
- [ ] Works with labeled and unlabeled target

### Feature 47: Cross-Disease Pre-training
- [ ] Pre-train on all diseases jointly
- [ ] Transfer to new disease
- [ ] Validated: faster convergence on new disease
- [ ] Pre-training curriculum studied
- [ ] Model checkpoint management

### Feature 48: Meta-Learning Adaptation
- [ ] MAML or Reptile implementation
- [ ] Few-shot adaptation (<100 samples)
- [ ] Validated: outperforms fine-tuning on small data
- [ ] Inner loop stability
- [ ] Adaptation speed measured

### Feature 49: Progressive Transfer
- [ ] Gradual unfreezing strategy
- [ ] Learning rate scheduling per layer
- [ ] Validated: reduces negative transfer
- [ ] Layer importance analysis
- [ ] Automated unfreezing schedule

### Feature 50: Contrastive Transfer
- [ ] Contrastive loss for representation alignment
- [ ] Cross-disease positive pairs
- [ ] Validated: better cluster separation
- [ ] Negative sampling strategy
- [ ] Temperature tuning

### Feature 51: Self-Supervised Pre-training
- [ ] Masked codon prediction task
- [ ] Contrastive sequence pairs
- [ ] Validated: improves all downstream tasks
- [ ] Large-scale unlabeled data usage
- [ ] Pre-training efficiency optimized

### Feature 52: Task-Agnostic Representations
- [ ] Disease-invariant latent space
- [ ] Task heads easily swappable
- [ ] Validated: single encoder for all diseases
- [ ] Representation analysis (probing)
- [ ] Latent space visualization

### Feature 53: Adapter Modules
- [ ] Bottleneck adapter architecture
- [ ] Parameter-efficient fine-tuning
- [ ] Validated: <5% new parameters, comparable performance
- [ ] Adapter fusion for multi-task
- [ ] Adapter sharing analysis

### Feature 54: LoRA for VAE
- [ ] Low-rank adaptation of encoder/decoder
- [ ] Rank selection strategy
- [ ] Validated: matches full fine-tuning
- [ ] Memory savings quantified
- [ ] LoRA merging for deployment

### Feature 55: Continual Learning
- [ ] Elastic weight consolidation
- [ ] Replay buffer for old tasks
- [ ] Validated: no catastrophic forgetting
- [ ] Task boundary detection
- [ ] Capacity management

---

## Category 6: Architecture (Features 56-70)

### Universal DoD for Architecture Features
- [ ] Integrates with existing training pipeline
- [ ] Memory efficient (documented requirements)
- [ ] Training time documented
- [ ] Ablation study included
- [ ] Architecture diagram provided

### Feature 56: Hierarchical VAE
- [ ] Multi-level latent hierarchy
- [ ] Top-down and bottom-up paths
- [ ] Validated: better reconstruction
- [ ] Latent space interpretability
- [ ] Level-wise training possible

### Feature 57: VQ-VAE for Codons
- [ ] Discrete codebook learned
- [ ] Codebook utilization >50%
- [ ] Validated: discrete captures codon structure
- [ ] Codebook analysis (clustering)
- [ ] Straight-through estimator stable

### Feature 58: Attention-Based VAE
- [ ] Self-attention in encoder
- [ ] Cross-attention for conditioning
- [ ] Validated: improves long-range dependencies
- [ ] Attention visualization
- [ ] Efficient attention (linear complexity)

### Feature 59: Flow-Based Decoder
- [ ] Normalizing flow decoder
- [ ] Exact likelihood computation
- [ ] Validated: better density estimation
- [ ] Flow architecture documented
- [ ] Invertibility verified

### Feature 60: Disentangled VAE
- [ ] Beta-VAE or Factor-VAE
- [ ] Disentanglement metrics (DCI, MIG)
- [ ] Validated: interpretable factors
- [ ] Factor traversal visualization
- [ ] Disentanglement vs reconstruction trade-off

### Feature 61: Conditional VAE
- [ ] Drug-conditioned generation
- [ ] Disease-conditioned generation
- [ ] Validated: conditions respected in generation
- [ ] Condition embedding strategy
- [ ] Conditional sampling interface

### Feature 62: Semi-Supervised VAE
- [ ] Labeled and unlabeled data jointly
- [ ] Classification with generation
- [ ] Validated: improves on limited labels
- [ ] Label propagation analysis
- [ ] Consistency regularization

### Feature 63: Info-VAE
- [ ] Maximum mean discrepancy term
- [ ] Better posterior matching
- [ ] Validated: reduces posterior collapse
- [ ] MMD kernel selection
- [ ] Comparison with KL-based VAE

### Feature 64: Two-Stage VAE
- [ ] Coarse then fine generation
- [ ] Hierarchical latent refinement
- [ ] Validated: higher quality generation
- [ ] Stage-wise training
- [ ] Latent space interpretation per stage

### Feature 65: Sparse VAE
- [ ] Sparse latent activations
- [ ] L1 or spike-and-slab prior
- [ ] Validated: interpretable sparse codes
- [ ] Sparsity level tuning
- [ ] Sparse code visualization

### Feature 66: Recurrent VAE
- [ ] LSTM/GRU encoder/decoder
- [ ] Variable-length sequences
- [ ] Validated: better on long sequences
- [ ] Hidden state analysis
- [ ] Attention over hidden states

### Feature 67: Wasserstein VAE
- [ ] Optimal transport loss
- [ ] Sinkhorn approximation
- [ ] Validated: better on high dimensions
- [ ] Transport plan visualization
- [ ] Comparison with KL-VAE

### Feature 68: Multi-Modal VAE
- [ ] Sequence + structure inputs
- [ ] Missing modality handling
- [ ] Validated: improves with both modalities
- [ ] Modality contribution analysis
- [ ] Cross-modal generation

### Feature 69: Memory-Augmented VAE
- [ ] External memory bank
- [ ] Attention over memory
- [ ] Validated: improves rare mutation handling
- [ ] Memory utilization analysis
- [ ] Memory update strategy

### Feature 70: Neural ODE VAE
- [ ] Continuous-depth model
- [ ] Adaptive ODE solver
- [ ] Validated: smooth latent dynamics
- [ ] Trajectory visualization
- [ ] Compute efficiency analysis

---

## Category 7: Epistasis (Features 71-80)

### Universal DoD for Epistasis Features
- [ ] Detects known epistatic pairs (positive control)
- [ ] Scales to 1000+ positions
- [ ] Interpretability: pairs can be explained
- [ ] Statistical significance computed
- [ ] Visualization of interactions

### Feature 71: Tensor Epistasis Network
- [ ] Pairwise interaction tensor
- [ ] Higher-order interactions (≥3-way)
- [ ] Validated: recovers known HIV interactions
- [ ] Sparse factorization for efficiency
- [ ] Interaction strength scores

### Feature 72: Sparse Epistasis
- [ ] L1 regularization on interactions
- [ ] Adaptive sparsity
- [ ] Validated: top-k interactions meaningful
- [ ] False discovery rate control
- [ ] Comparison with dense model

### Feature 73: Temporal Epistasis
- [ ] Time-series mutation data
- [ ] Interaction emergence over time
- [ ] Validated: captures compensatory dynamics
- [ ] Temporal visualization
- [ ] Causality estimation

### Feature 74: Cross-Gene Epistasis
- [ ] Interactions across genes
- [ ] Gene-pair embedding
- [ ] Validated: known cross-gene pairs detected
- [ ] Scales to 10+ genes
- [ ] Gene network visualization

### Feature 75: Compensatory Mutations
- [ ] Detects fitness-restoring pairs
- [ ] Directional epistasis (order matters)
- [ ] Validated: known compensatory pairs found
- [ ] Compensation score
- [ ] Clinical relevance annotation

### Feature 76: Fitness Landscape
- [ ] Reconstructs fitness from mutations
- [ ] Landscape visualization (2D projection)
- [ ] Validated: correlates with experimental fitness
- [ ] Peak and valley identification
- [ ] Pathway analysis

### Feature 77: Evolutionary Trajectory
- [ ] Predicts likely mutation paths
- [ ] Probability of trajectory
- [ ] Validated: observed paths ranked highly
- [ ] Trajectory visualization
- [ ] Intervention point identification

### Feature 78: Mutation Order Effects
- [ ] Order-dependent resistance
- [ ] Permutation importance
- [ ] Validated: order effects detected
- [ ] Order recommendation for treatment
- [ ] Historical order analysis

### Feature 79: Codon-Level Epistasis
- [ ] Synonymous codon interactions
- [ ] Codon pair bias effects
- [ ] Validated: codon optimization improved
- [ ] Species-specific patterns
- [ ] Expression correlation

### Feature 80: Structural Epistasis
- [ ] 3D contact-based interactions
- [ ] AlphaFold-guided pair selection
- [ ] Validated: structural contacts enriched
- [ ] Distance-dependent interaction strength
- [ ] Allosteric pathway detection

---

## Category 8: Clinical Integration (Features 81-90)

### Universal DoD for Clinical Features
- [ ] HIPAA/GDPR compliance documented
- [ ] Audit logging implemented
- [ ] Performance meets clinical SLAs
- [ ] User acceptance testing completed
- [ ] Clinical validation study designed

### Feature 81: FHIR R4 Integration
- [ ] DiagnosticReport resource generation
- [ ] Observation resources for predictions
- [ ] Patient resource linking
- [ ] FHIR validation passes
- [ ] Reference implementation server tested

### Feature 82: Clinical Decision API
- [ ] RESTful API with OpenAPI spec
- [ ] <100ms response time (p99)
- [ ] Rate limiting implemented
- [ ] Authentication (OAuth2)
- [ ] API versioning

### Feature 83: Automated Reports
- [ ] PDF report generation
- [ ] Configurable report templates
- [ ] Multi-language support
- [ ] Validated by clinical users
- [ ] Report archive and retrieval

### Feature 84: Clinical Alerts
- [ ] Real-time resistance alerts
- [ ] Configurable thresholds
- [ ] Multi-channel (email, SMS, pager)
- [ ] Alert acknowledgment tracking
- [ ] Alert audit trail

### Feature 85: Drug Interaction Checker
- [ ] Cross-reference drug databases
- [ ] Epistasis-informed interactions
- [ ] Severity classification
- [ ] Clinical decision support integration
- [ ] Drug-drug interaction matrix

### Feature 86: Treatment Recommendation
- [ ] Evidence-based recommendations
- [ ] Guideline compliance
- [ ] Personalized based on resistance
- [ ] Recommendation explanation
- [ ] Clinician feedback loop

### Feature 87: Resistance Timeline
- [ ] Longitudinal resistance tracking
- [ ] Trend visualization
- [ ] Resistance emergence prediction
- [ ] Integration with EHR
- [ ] Alert on resistance trends

### Feature 88: Surveillance Dashboard
- [ ] Real-time surveillance metrics
- [ ] Geographic visualization
- [ ] Outbreak detection
- [ ] Multi-hospital aggregation
- [ ] Role-based access control

### Feature 89: Quality Control Module
- [ ] Sample quality metrics
- [ ] Batch effects detection
- [ ] Contamination alerts
- [ ] QC report generation
- [ ] QC trend monitoring

### Feature 90: Regulatory Compliance
- [ ] FDA 510(k) submission package
- [ ] CE marking documentation
- [ ] Clinical trial data management
- [ ] Validation study protocols
- [ ] Post-market surveillance plan

---

## Category 9: Training & Optimization (Features 91-100)

### Universal DoD for Training Features
- [ ] Training time improvement measured
- [ ] Memory usage documented
- [ ] Reproducibility verified (seed control)
- [ ] Works with all model architectures
- [ ] Integration with training scripts

### Feature 91: Mixed Precision Training
- [ ] FP16/BF16 training
- [ ] Loss scaling implemented
- [ ] Validated: no accuracy loss
- [ ] Memory savings documented
- [ ] Speed improvement measured

### Feature 92: Gradient Checkpointing
- [ ] Memory-efficient backprop
- [ ] Configurable checkpoint segments
- [ ] Validated: enables larger models
- [ ] Training time trade-off documented
- [ ] Integration with existing models

### Feature 93: Distributed Training
- [ ] Multi-GPU training (DDP)
- [ ] Multi-node training
- [ ] Validated: near-linear scaling
- [ ] Fault tolerance
- [ ] Checkpoint synchronization

### Feature 94: Dynamic Batching
- [ ] Sequence length-based batching
- [ ] Maximizes GPU utilization
- [ ] Validated: faster training
- [ ] OOM prevention
- [ ] Integration with data loaders

### Feature 95: Curriculum Learning
- [ ] Easy-to-hard sample ordering
- [ ] Difficulty metric defined
- [ ] Validated: faster convergence
- [ ] Curriculum schedule
- [ ] Anti-curriculum comparison

### Feature 96: Label Smoothing
- [ ] Soft targets
- [ ] Calibration improvement
- [ ] Validated: reduces overconfidence
- [ ] Smoothing factor tuning
- [ ] Comparison with hard labels

### Feature 97: Stochastic Weight Averaging
- [ ] SWA implementation
- [ ] Learning rate schedule for SWA
- [ ] Validated: better generalization
- [ ] SWA-Gaussian for uncertainty
- [ ] Averaging schedule

### Feature 98: Knowledge Distillation
- [ ] Teacher-student training
- [ ] Soft target matching
- [ ] Validated: student matches teacher
- [ ] Compression ratio documented
- [ ] Multi-teacher distillation

### Feature 99: Neural Architecture Search
- [ ] Search space defined
- [ ] DARTS or weight-sharing NAS
- [ ] Validated: found architecture competitive
- [ ] Search cost documented
- [ ] Discovered architecture analysis

### Feature 100: Federated Learning
- [ ] Federated averaging
- [ ] Differential privacy integration
- [ ] Validated: privacy preserved, utility maintained
- [ ] Communication efficiency
- [ ] Non-IID data handling

---

## Verification Checklist Template

For each feature, use this checklist:

```
Feature #XX: [Name]
═══════════════════════════════════════
Date Started: ___________
Date Completed: ___________
Owner: ___________

Universal DoD:
[ ] Code quality (style, types, complexity)
[ ] Testing (90% coverage, all pass)
[ ] Documentation (API docs, examples)
[ ] Review (completed, no open comments)

Feature-Specific DoD:
[ ] Criterion 1
[ ] Criterion 2
[ ] Criterion 3
[ ] Criterion 4
[ ] Criterion 5

Sign-off:
[ ] Developer: ___________
[ ] Reviewer: ___________
[ ] Product Owner: ___________
```

---

## Change Log

| Date | Version | Changes |
|------|---------|---------|
| 2025-12-29 | 1.0.0 | Initial definitions of done |
